FIELD: biotechnology.
SUBSTANCE: invention relates to TSHR peptides in combination with an antithyroid agent and/or beta-blocker, and can be used in medicine for treating or preventing Graves' disease. A combined product comprising an effective amount of TSHR peptides with KKKKYVSIDVTLQQLESHKKK and GLKMFPDLTKVYSTD and an antithyroid agent and/or a beta-blocker.
EFFECT: invention provides inhibiting the production of autoantibodies to TSHR in vivo.
11 cl, 27 dwg, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION | 2015 |
|
RU2773344C2 |
| PEPTIDES | 2014 |
|
RU2676149C2 |
| REDUCED LEVELS OR ACTIVITY OF SYSTEMIC REGULATORY T CELLS FOR TREATING DISEASE OR CNS INJURY | 2015 |
|
RU2690670C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE | 2013 |
|
RU2696566C2 |
| LIPOSOMES RENDERING THYMUS-DEPENDENT ASSISTANCE TO "WEAK" ANTIGENS USED FOR PREPARING VACCINE | 1993 |
|
RU2107493C1 |
| FUSED PROTEINS OF CARCINOEMBRYONAL ANTIGEN | 2005 |
|
RU2380375C2 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPY SCHEMES BASED ON VACCINES | 2013 |
|
RU2609651C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF ALZHEIMER-TYPE DEMENTIA | 2013 |
|
RU2811687C2 |
| MONOCLONAL ANTIBODIES AGAINST IL-21 OF HUMAN BEING | 2008 |
|
RU2504552C2 |
| PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2582916C2 |
